353 related articles for article (PubMed ID: 31788340)
1. The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease.
Zhao Y; Zhang Y; Zhang L; Dong Y; Ji H; Shen L
Aging Dis; 2019 Dec; 10(6):1293-1301. PubMed ID: 31788340
[TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease.
Yang Y; Li Y; Yang H; Guo J; Li N
Front Mol Neurosci; 2021; 14():631553. PubMed ID: 33762908
[TBL] [Abstract][Full Text] [Related]
3. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
[TBL] [Abstract][Full Text] [Related]
4. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
Sørensen SS; Nygaard AB; Christensen T
Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
[TBL] [Abstract][Full Text] [Related]
6. The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease.
Samadian M; Gholipour M; Hajiesmaeili M; Taheri M; Ghafouri-Fard S
Front Aging Neurosci; 2021; 13():641080. PubMed ID: 33790780
[TBL] [Abstract][Full Text] [Related]
7. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
[TBL] [Abstract][Full Text] [Related]
8. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
9. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
11. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
Hong H; Li Y; Su B
J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435
[TBL] [Abstract][Full Text] [Related]
12. BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs.
Zeng T; Ni H; Yu Y; Zhang M; Wu M; Wang Q; Wang L; Xu S; Xu Z; Xu C; Xiong J; Jiang J; Luo Y; Wang Y; Liu H
J Chem Neuroanat; 2019 Jul; 98():87-96. PubMed ID: 30959172
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-125b as a biomarker of Alzheimer's disease.
Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNAs in Alzheimer's disease.
Tan L; Yu JT; Hu N; Tan L
Mol Neurobiol; 2013 Feb; 47(1):382-93. PubMed ID: 23054683
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
Müller M; Jäkel L; Bruinsma IB; Claassen JA; Kuiperij HB; Verbeek MM
Mol Neurobiol; 2016 Jul; 53(5):2894-2899. PubMed ID: 25895659
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis of Gene Expression and Identification of Biological Regulatory Mechanisms in Alzheimer's Disease.
Su L; Chen S; Zheng C; Wei H; Song X
Front Neurosci; 2019; 13():633. PubMed ID: 31333395
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-Target Interaction Regulatory Network in Alzheimer's Disease.
Turk A; Kunej T; Peterlin B
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945753
[TBL] [Abstract][Full Text] [Related]
18. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
Dangla-Valls A; Molinuevo JL; Altirriba J; Sánchez-Valle R; Alcolea D; Fortea J; Rami L; Balasa M; Muñoz-García C; Ezquerra M; Fernández-Santiago R; Lleó A; Lladó A; Antonell A
Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
[TBL] [Abstract][Full Text] [Related]
19. miR-15b represses BACE1 expression in sporadic Alzheimer's disease.
Gong G; An F; Wang Y; Bian M; Yu LJ; Wei C
Oncotarget; 2017 Oct; 8(53):91551-91557. PubMed ID: 29207665
[TBL] [Abstract][Full Text] [Related]
20. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
Nunomura A; Perry G
Oxid Med Cell Longev; 2020; 2020():2638130. PubMed ID: 33312335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
